Aphl 2 Limited

The principal activity of the Company during the period was that of a holding company of Aspire Pharma Limited (Aspire, collectively the Group). The principal activity of the Group during the year was that of the development, registration, marketing, and distribution of branded and generic pharmaceutical products. As a healthcare Group our business expertise lies in the research, development and licensing of new products. The Group identifies niche molecules in a wide range of therapeutic areas which have enabled it to develop products which have been traditionally seen as difficult and thus enabling it to lead the market. All Aspire Pharma products are manufactured to the highest standard, in MHRA/ EU, GMP compliant and approved manufacturing sites.